Singapore markets closed

ResMed Inc. (RMD)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
218.06+34.64 (+18.89%)
At close: 04:00PM EDT
217.99 -0.07 (-0.03%)
After hours: 05:50PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 26.98B
Enterprise value 28.16B
Trailing P/E 30.37
Forward P/E 22.99
PEG ratio (5-yr expected) 1.73
Price/sales (ttm)6.01
Price/book (mrq)6.02
Enterprise value/revenue 6.25
Enterprise value/EBITDA 19.69

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-23.88%
S&P500 52-week change 321.08%
52-week high 3243.52
52-week low 3132.24
50-day moving average 3186.01
200-day moving average 3172.35

Share statistics

Avg vol (3-month) 31.02M
Avg vol (10-day) 31.21M
Shares outstanding 5147.09M
Implied shares outstanding 6147.09M
Float 8145.52M
% held by insiders 10.82%
% held by institutions 158.71%
Shares short (15 Apr 2024) 47.95M
Short ratio (15 Apr 2024) 47.89
Short % of float (15 Apr 2024) 46.16%
Short % of shares outstanding (15 Apr 2024) 45.40%
Shares short (prior month 15 Mar 2024) 47.66M

Dividends & splits

Forward annual dividend rate 41.92
Forward annual dividend yield 41.05%
Trailing annual dividend rate 30.44
Trailing annual dividend yield 30.24%
5-year average dividend yield 40.87
Payout ratio 430.46%
Dividend date 314 Mar 2024
Ex-dividend date 407 Feb 2024
Last split factor 22:1
Last split date 331 Aug 2010

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2021
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 20.91%
Operating margin (ttm)31.29%

Management effectiveness

Return on assets (ttm)11.91%
Return on equity (ttm)22.39%

Income statement

Revenue (ttm)4.58B
Revenue per share (ttm)31.17
Quarterly revenue growth (yoy)7.20%
Gross profit (ttm)N/A
EBITDA 1.44B
Net income avi to common (ttm)958.38M
Diluted EPS (ttm)6.03
Quarterly earnings growth (yoy)29.20%

Balance sheet

Total cash (mrq)237.91M
Total cash per share (mrq)1.62
Total debt (mrq)1.17B
Total debt/equity (mrq)25.21%
Current ratio (mrq)3.04
Book value per share (mrq)31.50

Cash flow statement

Operating cash flow (ttm)1.2B
Levered free cash flow (ttm)926.74M